Sanofi-Aventis Sa (SNY)

$ 34.31

Latest ShareCast News

By Benjamin Chiou

Date: Monday 04 Oct 2010

Sanofi-Aventis has launched an $18.5bn hostile bid for Genzyme after the American drugs giant turned down its previous offer.

No recent information was found.

Buffett's Berkshire defends valuation of 5 stocks	30-Mar-2011	USA Today
Genzyme: Sanofi-Aventis to buy U.S. biotech comp...	17-Feb-2011	BayArea.com
Sanofi Agrees to Buy Genzyme for $20.1 Billion	17-Feb-2011	New York Times
Genzyme Again Rejects Sanofi’s Bid	08-Oct-2010	New York Times
Sanofi-Aventis launches takeover battle for Genz...	05-Oct-2010	LA Times

Patent Woes Threaten Drug Firms	07-Mar-2011	New York Times
Sanofi Bid for Genzyme Turns Hostile, and No Swe...	05-Oct-2010	Intl Herald Tribune
Stocks end the beginning of a busy week down	05-Oct-2010	Wall Street Journal
Stocks fall at the beginning of a busy week	05-Oct-2010	LA Times
Stocks end the trading day with big losses	31-Aug-2010	Wall Street Journal

No recent information was found.

FDA Licenses New Influenza Vaccine Designed Spec...	23-Dec-2009	PR Newswire
Sanofi-aventis to Acquire Chattem Inc., Creating...	21-Dec-2009	PR Newswire
Sanofi Pasteur Obtains License from Syntiron to ...	16-Dec-2009	PR Newswire
Sanofi Pasteur Expands Study of Vaccine Against ...	15-Dec-2009	PR Newswire
New Executive Leadership and CEO Announced for B...	11-Dec-2009	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.